trending Market Intelligence /marketintelligence/en/news-insights/trending/bncoifdzp0q3k4paxrsphq2 content esgSubNav
In This List

Nemus Bioscience closes $1.8M private placement

Blog

Global Capital Markets & SPAC Activity – H1 2021

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management


Nemus Bioscience closes $1.8M private placement

Nemus Bioscience Inc. received about $1.8 million in the final closing of a private placement with Emerald Health Sciences Inc.

Emerald Health bought 15 million ordinary Nemus shares and warrants to buy an additional 20.4 million shares at 10 cents apiece.

On a fully converted basis, Emerald holds a majority of Nemus' outstanding share capital.

Costa Mesa, Calif.-based Nemus intends to use proceeds for working capital and to explore potential strategic opportunities.

Emerald Health and Nemus are focused on cannabinoid-based therapeutics.